AR035524A1 - Sulfamidotienopirimidinas, un procedimiento para su preparacion, el uso de las mismas para la preparacion de un medicamento, los medicamentos que las comprenden, un conjunto (kit) que las incluye, las preparaciones farmaceuticas que las contienen, y un procedimiento para preparar estas preparaciones - Google Patents
Sulfamidotienopirimidinas, un procedimiento para su preparacion, el uso de las mismas para la preparacion de un medicamento, los medicamentos que las comprenden, un conjunto (kit) que las incluye, las preparaciones farmaceuticas que las contienen, y un procedimiento para preparar estas preparacionesInfo
- Publication number
- AR035524A1 AR035524A1 ARP010105889A ARP010105889A AR035524A1 AR 035524 A1 AR035524 A1 AR 035524A1 AR P010105889 A ARP010105889 A AR P010105889A AR P010105889 A ARP010105889 A AR P010105889A AR 035524 A1 AR035524 A1 AR 035524A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- preparation
- compound
- procedure
- hal
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 4
- 239000003814 drug Substances 0.000 title abstract 3
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 2
- 229940126601 medicinal product Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 6
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 2
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000002993 cycloalkylene group Chemical group 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000012453 solvate Substances 0.000 abstract 2
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 1
- 101100054666 Streptomyces halstedii sch3 gene Proteins 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- -1 heteroaromatic radical Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000002590 phosphodiesterase V inhibitor Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 230000001131 transforming effect Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Vascular Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Gynecology & Obstetrics (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Sulfamidotienopirimidinas de fórmula (1), en donde: R1 y R2 son cada uno, independientemente entre sí, H, OA1, OCOA1, OH o Hal, donde R1 y R2 como alternativa son en conjunto alquileno C3-5, -O-CH2-CH2-, -CH2-O-CH2-, -O-CH2-O- o -O-CH2-CH2-O-; X es CH2SO2NR3R4; R3 y R4, independientemente entre sí, son H, un radical heteroaromático, alquilo o alquenilo C1-10, cada uno de los cuales es monosustituido o sustituido en posición terminal por -NH2, -NHA1 o -NA1A2 y donde uno o dos grupos CH2 pueden ser reemplazados por grupos -CH=CH, -O, -NH o -NA, donde R3 y R4, como alternativa, son en conjunto cicloalquilo o cicloalquileno con C3-7, cada uno de los cuales es insustituido o monosustituido o polisustituido por -Hal, -NH2, -NHA, -NA1A2, -NHCOA1, NHCOOA1, -COOH, -COOA1, -CONH2, -CONHA1 o -CONA1A2 y donde uno o dos grupos -CH2 pueden ser reemplazados por -O, -NH, -NA1, -NCOA1 o -NCOOA1; A1 y A2 son cada uno, independientemente entre sí, alquilo o alquenilo con C1-10, cada uno de los cuales puede ser sustituido por 1 y 5 átomos de F y/o Cl, donde A1 y A2, como alternativa, son en conjunto cicloalquilo o cicloalquileno con C3-7, donde un grupo CH2 puede ser reemplazado por -O. -NH, -NA1, -NCOA1 o -NCOOA1, y Hal es F, Cl, Br o I, y sus sales y/o solvatos. Un procedimiento para preparar los compuestos de fórmula (1), que comprende los pasos de: a) hacer reaccionar un compuesto de fórmula (2) donde: X es -CH2SO2NR3R4, y L es Cl, Br, OH, SCH3 o un grupo OH esterificado y reactivo, con un compuesto de fórmula (3), donde: R1 y R2 tienen los valores definidos más arriba o b) hacer reaccionar un compuesto de fórmula (4)donde: Y es -CH2SO2Q; Q es Cl, Br, OH o un grupo OH esterificado y reactivo, y R1 y R2 tienen los valores definidos más arriba, con un compuesto de fórmula (5): HNR3R4; donde R3 y R4 tienen los valores definidos más arriba; y/o transformar un compuesto de fórmula (1) en una de sus sales y/o solvatos. Las preparaciones farmacéuticas y medicamentos que contienen las sulfamidotienopirimidinas de fórmula (1), un conjunto (kit) que las incluye, y el uso de las mismas como inhibidores de la fosfodiesterasa V y para la preparación de un medicamento para el tratamiento o profilaxis de enfermedades que son causadas por un nivel de GMPc excesivamente bajo y/o pueden ser afectadas por un aumento en el nivel de GMPc.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10064994A DE10064994A1 (de) | 2000-12-23 | 2000-12-23 | Sulfamidothienopyrimidine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR035524A1 true AR035524A1 (es) | 2004-06-02 |
Family
ID=7668967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP010105889A AR035524A1 (es) | 2000-12-23 | 2001-12-19 | Sulfamidotienopirimidinas, un procedimiento para su preparacion, el uso de las mismas para la preparacion de un medicamento, los medicamentos que las comprenden, un conjunto (kit) que las incluye, las preparaciones farmaceuticas que las contienen, y un procedimiento para preparar estas preparaciones |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7019013B2 (es) |
| EP (1) | EP1353927B1 (es) |
| JP (1) | JP4550361B2 (es) |
| KR (1) | KR20030062438A (es) |
| CN (1) | CN1483035A (es) |
| AR (1) | AR035524A1 (es) |
| AT (1) | ATE302781T1 (es) |
| BR (1) | BR0115996A (es) |
| CA (1) | CA2432582C (es) |
| CZ (1) | CZ20031815A3 (es) |
| DE (2) | DE10064994A1 (es) |
| ES (1) | ES2247007T3 (es) |
| HU (1) | HUP0302515A3 (es) |
| MX (1) | MXPA03005714A (es) |
| PL (1) | PL361733A1 (es) |
| RU (1) | RU2003122189A (es) |
| SK (1) | SK8432003A3 (es) |
| WO (1) | WO2002051848A2 (es) |
| ZA (1) | ZA200305659B (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005503345A (ja) * | 2001-04-30 | 2005-02-03 | バイエル・コーポレーシヨン | 新規な４−アミノ−５，６−置換チオフェノ［２，３−ｄ］ピリミジン |
| EP1847543A1 (de) | 2006-04-19 | 2007-10-24 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen |
| DE502006004066D1 (de) * | 2006-04-19 | 2009-08-06 | Boehringer Ingelheim Pharma | Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen |
| US8080549B2 (en) * | 2007-01-12 | 2011-12-20 | Concert Pharmaceuticals, Inc. | Endothelin receptor antagonists |
| WO2008088727A2 (en) | 2007-01-12 | 2008-07-24 | Concert Pharmaceuticals, Inc. | Endothelin receptor antagonists |
| KR20090112722A (ko) | 2007-01-24 | 2009-10-28 | 글락소 그룹 리미티드 | 3,5-디아미노-6-(2,3-디클로로페닐)-1,2,4-트리아진 또는 ｒ(-)-2,4-디아미노-5-(2,3-디클로로페닐)-6-플루오로메틸 피리미딘 및 ｎｋ1을 포함하는 제약 조성물 |
| JP5563466B2 (ja) | 2007-10-19 | 2014-07-30 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規ピペラジノ−ジヒドロチエノピリミジン誘導体 |
| ATE542825T1 (de) | 2007-10-19 | 2012-02-15 | Boehringer Ingelheim Int | Substituierte piperidino-dihydrothienopyrimidine |
| JP5341899B2 (ja) | 2007-10-19 | 2013-11-13 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ヘテロ環置換ピペラジノ−ジヒドロチエノピリミジン |
| AU2011281015B2 (en) | 2010-07-23 | 2015-09-24 | President And Fellows Of Harvard College | Tricyclic proteasome activity enhancing compounds |
| US9802954B2 (en) | 2011-08-24 | 2017-10-31 | Boehringer Ingelheim International Gmbh | Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma |
| US20130059866A1 (en) | 2011-08-24 | 2013-03-07 | Boehringer Ingelheim International Gmbh | Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma |
| EP2806875B1 (en) | 2012-01-25 | 2017-07-19 | Proteostasis Therapeutics, Inc. | Proteasome activity modulating compounds |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19644228A1 (de) * | 1996-10-24 | 1998-04-30 | Merck Patent Gmbh | Thienopyrimidine |
| DE19752952A1 (de) * | 1997-11-28 | 1999-06-02 | Merck Patent Gmbh | Thienopyrimidine |
| DE19819023A1 (de) * | 1998-04-29 | 1999-11-04 | Merck Patent Gmbh | Thienopyrimidine |
| EP1323719A1 (en) | 1999-03-30 | 2003-07-02 | Nippon Soda Co., Ltd. | Thienopyrimidine compounds and salts thereof and process for the preparation of the same |
-
2000
- 2000-12-23 DE DE10064994A patent/DE10064994A1/de not_active Withdrawn
-
2001
- 2001-12-03 JP JP2002552942A patent/JP4550361B2/ja not_active Expired - Fee Related
- 2001-12-03 BR BR0115996-8A patent/BR0115996A/pt not_active Application Discontinuation
- 2001-12-03 ES ES01271992T patent/ES2247007T3/es not_active Expired - Lifetime
- 2001-12-03 US US10/451,183 patent/US7019013B2/en not_active Expired - Fee Related
- 2001-12-03 MX MXPA03005714A patent/MXPA03005714A/es not_active Application Discontinuation
- 2001-12-03 CN CNA018212190A patent/CN1483035A/zh active Pending
- 2001-12-03 PL PL01361733A patent/PL361733A1/xx unknown
- 2001-12-03 AT AT01271992T patent/ATE302781T1/de not_active IP Right Cessation
- 2001-12-03 CA CA2432582A patent/CA2432582C/en not_active Expired - Fee Related
- 2001-12-03 SK SK843-2003A patent/SK8432003A3/sk unknown
- 2001-12-03 KR KR10-2003-7008265A patent/KR20030062438A/ko not_active Withdrawn
- 2001-12-03 WO PCT/EP2001/014102 patent/WO2002051848A2/de not_active Ceased
- 2001-12-03 HU HU0302515A patent/HUP0302515A3/hu unknown
- 2001-12-03 RU RU2003122189/04A patent/RU2003122189A/ru not_active Application Discontinuation
- 2001-12-03 EP EP01271992A patent/EP1353927B1/de not_active Expired - Lifetime
- 2001-12-03 CZ CZ20031815A patent/CZ20031815A3/cs unknown
- 2001-12-03 DE DE50107230T patent/DE50107230D1/de not_active Expired - Lifetime
- 2001-12-19 AR ARP010105889A patent/AR035524A1/es not_active Application Discontinuation
-
2003
- 2003-07-22 ZA ZA200305659A patent/ZA200305659B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US7019013B2 (en) | 2006-03-28 |
| US20040063943A1 (en) | 2004-04-01 |
| HUP0302515A3 (en) | 2005-06-28 |
| JP2004516329A (ja) | 2004-06-03 |
| CZ20031815A3 (cs) | 2003-10-15 |
| EP1353927A2 (de) | 2003-10-22 |
| DE50107230D1 (de) | 2005-09-29 |
| CN1483035A (zh) | 2004-03-17 |
| ES2247007T3 (es) | 2006-03-01 |
| KR20030062438A (ko) | 2003-07-25 |
| WO2002051848A2 (de) | 2002-07-04 |
| CA2432582A1 (en) | 2002-07-04 |
| ZA200305659B (en) | 2004-08-27 |
| WO2002051848A3 (de) | 2002-10-24 |
| EP1353927B1 (de) | 2005-08-24 |
| DE10064994A1 (de) | 2002-07-04 |
| PL361733A1 (en) | 2004-10-04 |
| ATE302781T1 (de) | 2005-09-15 |
| JP4550361B2 (ja) | 2010-09-22 |
| SK8432003A3 (en) | 2003-10-07 |
| RU2003122189A (ru) | 2004-12-27 |
| MXPA03005714A (es) | 2003-10-06 |
| HUP0302515A2 (hu) | 2003-11-28 |
| CA2432582C (en) | 2011-01-25 |
| BR0115996A (pt) | 2004-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR035524A1 (es) | Sulfamidotienopirimidinas, un procedimiento para su preparacion, el uso de las mismas para la preparacion de un medicamento, los medicamentos que las comprenden, un conjunto (kit) que las incluye, las preparaciones farmaceuticas que las contienen, y un procedimiento para preparar estas preparaciones | |
| SE9904738D0 (sv) | Novel compounds | |
| BRPI0108395B8 (pt) | derivados de pirrolopirimidinona, processos de preparação e uso | |
| MXPA04004601A (es) | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. | |
| ES2061452T3 (es) | Nuevas hetrazepinas y procedimiento para su preparacion. | |
| SE9904505D0 (sv) | Novel compounds | |
| ECSP066314A (es) | Derivados piridilo y su uso como agentes terapéuticos | |
| UY27592A1 (es) | Nuevo uso | |
| BR0312513A (pt) | Derivados de glicosìdeo de tiofeno, processos para a produção dos mesmos, medicamentos que contêm esses compostos e uso dos mesmos | |
| MX9300786A (es) | Compuestos hipolipidaemicos. | |
| NO20023933D0 (no) | Nye forbindelser | |
| AR024060A1 (es) | Nuevos compuestos farmaceuticamente activos | |
| AR044006A1 (es) | Compuesto de fenilpiperidinilo, su uso para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para la preparacion de dicho compuesto | |
| ES2058504T3 (es) | Derivados de piperidina y piperazina, procedimiento para preparar los mismos, y composiciones farmaceuticas que contienen los mismos. | |
| ES2058749T3 (es) | Derivados 2-aminopirimidinona. | |
| DK84181A (da) | Derivater af 3,4,5-trihydroxypiperidin,fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler samt til dyreernaering | |
| BR0106248A (pt) | Inibidores de metaloprotease, processo para a sua preparação e composições farmacêuticas contendo os mesmos | |
| ATE400552T1 (de) | 4,4' -dithiobis- (3-aminobutane-1-sulfonate)- derivate und sie enthaltende zusammensetzungen | |
| FI803202L (fi) | Fosfonohydroxiaettiksyra foerfarande foer dess framstaellning och dess anvaendning saosom laekemedel | |
| TW200718423A (en) | Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and pharmaceutical composition thereof | |
| DK624989A (da) | Makrolidforbindelser | |
| ATE25691T1 (de) | Synergistine derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| AR002264A1 (es) | 6-[triazolil[3(trifluormetil)fenil]metil]-2-quinolinonas y quinolintionas, un procedimiento para su preparacion, una composicion que las comprende, unprocedimiento para su preparacion, el uso de las mismas para la preparacion de un medicamento y un intermediario. | |
| ES2037758T3 (es) | Un metodo de uso de un derivado quinolincarboxilico y su procedimiento de preparacion. | |
| SE8302345L (sv) | Pleuromutilinderivat, forfaranden for deras framstellning och deras anvendning som lekemedel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal | ||
| FC | Refusal |